Previous 10 | Next 10 |
home / stock / nsrgy / nsrgy news
Shares of the peanut allergy drugmaker Aimmune Therapeutics (NASDAQ: AIMT) jumped by a jaw-dropping 159% during August, according to data provided by S&P Global Market Intelligence . The biopharma's shares took flight last month after the announcement of a $2.6 billion merger agreement...
This article is part of a series that provides an ongoing analysis of the changes made to Gardner Russo & Gardner’s 13F stock portfolio on a quarterly basis. It is based on Russo’s regulatory 13F Form filed on 08/14/2020. Please visit our Tracking Gardner Russo & Gardn...
A recent buyout offer for Aimmune (NASDAQ: AIMT) from its deep-pocketed collaboration partner, Nestle (OTC: NSRGY) , drove the biotech stock around 172% higher overnight. As is usually the case following one of these lucrative cash deals, lots of investors have started searching the healt...
The U.S. Federal Trade Commission (FTC) has voted 3-1-1 approving a final order settling charges that AbbVie's ( ABBV +0.1% ) $63B takeover of Allergan would violate federal antitrust law. More news on: AbbVie Inc., Nestlé S.A., AstraZeneca PLC, Healthcare stocks news, Merger &...
Monday was a mixed day on Wall Street, as the Dow Jones Industrial Average (DJINDICES: ^DJI) and S&P 500 (SNPINDEX: ^GSPC) lost ground despite another record showing for the Nasdaq Composite. Yet even with the losses for the day, the Dow and S&P were up around 8% in August, strin...
Shares of Aimmune Therapeutics (NASDAQ: AIMT) jumped by an eye-popping 170% in pre-market trading Monday morning. The biotech's stock is screaming higher this morning in response to a $2.6 billion merger agreement -- on a fully diluted basis -- with Nestle 's (OTC: NSRGY) Health Science d...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . High profile stock splits Excitement is percolating around two of the market's favorite stocks as Apple (NASDAQ:AAPL) begins trading...
Nestle's ( OTCPK:NSRGY ) Health Scinece division (NHSc) has entered into a definitive agreement to acquire peanut allergy treatment maker Aimmune Therapeutics (NASDAQ: AIMT ) . More news on: Nestlé S.A., Aimmune Therapeutics, Inc., Nestlé S.A., Healthcare stocks news, Re...
This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 08/17/2020. Please visit our Tracking Dan Loeb’s Third Point Portfoli...
We made over a 40% return on our short position in Beyond Meat (BYND) in less than two months after we announced that we're shorting the stock at ~$110 per share in early February. Our DCF model back then showed that the company trades at a premium and its stock has all the chances to deprec...
News, Short Squeeze, Breakout and More Instantly...
Nestle SA ADR Reg Shs Ser B Company Name:
NSRGY Stock Symbol:
OTCMKTS Market:
2024-07-16 07:20:00 ET Between fundraising, legislating, and engaging in a number of other responsibilities, the politicians who serve in Washington, D.C., are busy. Many of them, however, find enough time to buy and sell stocks. And because many politicians demonstrate an uncanny ability t...